High-level expression of foreign genes in vivo and in vitro by improved DNA-based replicon vector derived from Semliki Forest virus

Progress in Biochemistry and Biophysics

Volumn 33, Issue 1, 2006, Pages 87-94

  Yu, Yun Zhou ^a   Sun, Zhi Wei ^a   Liu, Zhi Gang ^a   Yu, Wei Yuan ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

DNA; Recombinant virus particle; RNA replicon; Semliki Forest virus; Vaccine

Indexed keywords

ALPHAVIRUS; CUCUMBER MOSAIC VIRUS; EUKARYOTA; RABBIT FIBROMA VIRUS; SEMLIKI FOREST VIRUS;

EID: 33645790750     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jonathan O R, Sergey A D, Kurt I K. Alphavirus vectors and vaccination. Rev Med Virol, 2002, 12 (5): 279-296
2. Lundstrom K. Semliki Forest virus vectors for gene therapy. Expert Opin Biol Ther, 2003, 3 (5): 771-777
3. Yu YZ, Sun Z W, Yu W Y. Chinese Journal of Biotechnology, 2005, 21 (5): 33-38
4. Boyer J C, Haenni A L. Infectious transcripts and cDNA clones of RNA viruses. Virology, 1994, 198 (2): 415-426
5. Perrotta A T, Been M D. A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature, 1991, 350 (6317): 434-436
6. Berglund P, Sjoberg M, Garoff H, et al. Semliki Forest virus expression system: produence of conditionally infectious recombinant particles. Biotechnolgy, 1993, 11 (8): 916-920
7. Herweijer H, Latendresse J S, Williams P, et al. A plasmid-based self-amplifying Sindbis virus vector. Hum Gene Ther, 1995, 6 (9): 1161-1167
8. Dubensky JRTW, Driver D A, Polo J M, et al. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol, 1996, 70 (1): 508-519
9. DiCiommo D P, Rod B. Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem, 1998, 273 (29): 18060-18066
10. Kohno A, Emi N, Kasai M, et al. Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death. Gene Ther, 1998, 5 (3): 415-418
11. Lundstrom K. Alphavirus vectors for vaccines production and gene therapy. Expert Rev Vaccines, 2003, 2 (3): 447-459
12. Xanthopoulos K G. Development of improved Sindbis virus-based DNA expression vector. DNA Cell Biol, 2004, 23 (2): 75-80
13. Polo J M, Belli B A, Driver D A, et al. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proc Natl Acad Sci USA, 1999, 96 (8): 4598-4603
14. Leitner W W, Hwang L N, Deveer M J, et al. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med, 2003, 9 (1): 33-39
15. Leitner W W, Ying H, Driver D A, et al. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Research, 2000, 60 (1): 51-55
16. Leimer W W, Hwang L N, Bergmann-Leitner E S, et al. Apoptosis is essential for the increased efficacy of alphavirus-based DNA vaccines. Vaccine, 2004, 22 (11-12): 1537-1544